{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:02:18Z","timestamp":1773936138130,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.toxicon.2026.109060","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:58:53Z","timestamp":1773129533000},"page":"109060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A mechanistic computational cell-based potency assay for botulinum neurotoxin A enables transparent potency estimation and cross-assay harmonization"],"prefix":"10.1016","volume":"275","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8443-8338","authenticated-orcid":false,"given":"Eqram","family":"Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golam","family":"Saklayen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parinitha","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3969-9480","authenticated-orcid":false,"given":"Alexander","family":"Nassif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5801-2105","authenticated-orcid":false,"given":"John H.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2701-626X","authenticated-orcid":false,"given":"William Richard","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2026.109060_bib1","author":"Azzaz"},{"key":"10.1016\/j.toxicon.2026.109060_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41597-022-01710-x","article-title":"Introducing the FAIR principles for research software","volume":"9","author":"Barker","year":"2022","journal-title":"Sci. Data"},{"key":"10.1016\/j.toxicon.2026.109060_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/toxins12020072","article-title":"Reply to comment on Re-Visiting immunogenicity associated with botulinum toxin treatment. Toxins 2019, 11, 491","volume":"12","author":"Bellows","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2026.109060_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41586-018-0409-3","article-title":"Genetic and transcriptional evolution alters cancer cell line drug response","volume":"560","author":"Ben-David","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2026.109060_bib5","article-title":"Comparison of methods: passing and bablok regression","volume":"49\u201352","author":"Bilic-Zulle","year":"2011","journal-title":"Biochem. Med."},{"key":"10.1016\/j.toxicon.2026.109060_bib6","article-title":"A probabilistic modeling framework for genomic networks incorporating sample heterogeneity","volume":"5","author":"Chen","year":"2025","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.toxicon.2026.109060_bib7","series-title":"ICH Q2(R2) Validation of Analytical Procedures - Scientific Guideline. Amsterdam","year":"2023"},{"key":"10.1016\/j.toxicon.2026.109060_bib8","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1073\/pnas.1507125112","article-title":"A survey of human brain transcriptome diversity at the single cell level","volume":"112","author":"Darmanis","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.toxicon.2026.109060_bib9","article-title":"Botulinum toxin: preparations for clinical use, immunogenicity, side effects, and safety profile","volume":"36","author":"Dashtipour","year":"2016","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.toxicon.2026.109060_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/srep14364","article-title":"Translational compensation of genomic instability in neuroblastoma","volume":"5","author":"Dassi","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxicon.2026.109060_bib11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4103\/IJMR.2010_132_05_489","article-title":"Botulinum toxin: Bioweapon & magic drug","volume":"132","author":"Dhaked","year":"2010","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.toxicon.2026.109060_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000083259","article-title":"Botulinum toxin: mechanisms of action","volume":"53","author":"Dressler","year":"2005","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.toxicon.2026.109060_bib13","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00702-022-02535-z","article-title":"Potency of botulinum toxin drugs: test systems and labelling","volume":"129","author":"Dressler","year":"2022","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.toxicon.2026.109060_bib14","doi-asserted-by":"crossref","first-page":"7524","DOI":"10.3390\/ijms22147524","article-title":"Emerging opportunities in human pluripotent stem-cells based assays to explore the diversity of botulinum neurotoxins as future therapeutics","volume":"22","author":"Duchesne de Lamotte","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxicon.2026.109060_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049516","article-title":"Botulinum neurotoxin serotype a specific cell-based potency assay to replace the mouse bioassay","volume":"7","author":"Fern\u00e1ndez-Salas","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2026.109060_bib16","article-title":"Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal","volume":"33","author":"Ferrari","year":"2018","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.toxicon.2026.109060_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/toxins15050314","article-title":"Replacement of the mouse LD50 assay for determination of the potency of AbobotulinumtoxinA with a cell-based method in both powder and liquid formulations","volume":"15","author":"Fonfria","year":"2023","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2026.109060_bib18","series-title":"Q2 (R2) Validation of Analytical Procedures Guidance for Industry","year":"2024"},{"issue":"1979","key":"10.1016\/j.toxicon.2026.109060_bib19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1126\/science.aad7038","article-title":"Div-Seq: Single-nucleus RNA-Seq reveals dynamics of rare adult newborn neurons","volume":"353","author":"Habib","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.toxicon.2026.109060_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-023-02040-y","article-title":"Mosaic integration and knowledge transfer of single-cell multimodal data with MIDAS","volume":"42","author":"He","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.toxicon.2026.109060_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11070418","article-title":"Rapid detection of Botulinum Neurotoxins-A review","author":"Hobbs","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2026.109060_bib22","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/(SICI)1097-0215(19970917)72:6<1070::AID-IJC23>3.0.CO;2-7","article-title":"Extensive genetic heterogeneity in the neuroblastoma cell line NB(TU)1","volume":"72","author":"Inoue","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.toxicon.2026.109060_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2021.12.012","article-title":"New horizons in the stormy sea of multimodal single-cell data integration","author":"Jackson","year":"2022","journal-title":"Mol. Cell."},{"key":"10.1016\/j.toxicon.2026.109060_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/minf.201400137","article-title":"Establishing Good Computer Modelling Practice (GCMP) in the prediction of chemical toxicity","volume":"34","author":"Judson","year":"2015","journal-title":"Mol. Inform."},{"key":"10.1016\/j.toxicon.2026.109060_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.patter.2021.100198","article-title":"Latent representation learning in biology and translational medicine","volume":"2","author":"Kopf","year":"2021","journal-title":"Patterns"},{"key":"10.1016\/j.toxicon.2026.109060_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-023-01826-4","article-title":"Integration of multi-modal single-cell data","author":"Lee","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.toxicon.2026.109060_bib27","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/(SICI)1096-987X(199608)17:11<1287::AID-JCC1>3.0.CO;2-I","article-title":"Simultaneous integration of mixed quantum-classical systems by density matrix evolution equations using interaction representation and adaptive time step integrator","volume":"17","author":"Lensink","year":"1996","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.toxicon.2026.109060_bib28","author":"Levine"},{"key":"10.1016\/j.toxicon.2026.109060_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2019.11.010","article-title":"Structural insights into the interaction of botulinum neurotoxin a with its neuronal receptor SV2C","volume":"175","author":"Li","year":"2020","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2026.109060_bib30","first-page":"257","article-title":"Progress in cell based assays for botulinum Neurotoxin detection","author":"Pellett","year":"2012","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.toxicon.2026.109060_bib31","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.3390\/toxins7114519","article-title":"Current status and future directions of botulinum neurotoxins for targeting pain processing","volume":"7","author":"Pellett","year":"2015","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2026.109060_bib32","doi-asserted-by":"crossref","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum neurotoxins: biology, pharmacology, and toxicology","author":"Pirazzini","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.toxicon.2026.109060_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2025.108548","article-title":"In Silico Multiscale computational modelling of botulinum toxin A diffusion for glabellar wrinkle treatment: optimizing injection volumes across formulations","author":"Rahman","year":"2025","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2026.109060_bib34","article-title":"Computational modelling the impact of GLP-1 receptor agonists on botulinum toxin A: evidence for reduced treatment durability across neurologic and aesthetic indications","volume":"269","author":"Rahman","year":"2025","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2026.109060_bib35","article-title":"Computational model-informed comparative evaluation of botulinum toxin A formulations: a 20-Year simulation of onset","author":"Rahman","year":"2025","journal-title":"Diffusion, Duration, and Immunogenicity. Toxicon"},{"key":"10.1016\/j.toxicon.2026.109060_bib36","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/toxins17100498","article-title":"Computational modelling suggests bacteriostatic saline does not reverse botulinum toxin-induced brow ptosis","volume":"17","author":"Rahman","year":"2025","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2026.109060_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/toxins17040182","article-title":"Computational immunogenetic analysis of botulinum toxin A immunogenicity and HLA gene haplotypes: new insights","volume":"17","author":"Rahman","year":"2025","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2026.109060_bib38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00238-025-02331-4","article-title":"Beyond binary endpoints: modernizing aesthetic trial analytics: Simulation-Based reappraisal of phase 2\/3 BoNT-A studies using advanced statistical models","volume":"48","author":"Rahman","year":"2025","journal-title":"Eur. J. Plast. Surg."},{"key":"10.1016\/j.toxicon.2026.109060_bib39","article-title":"Engineering Botulinum neurotoxins for enhanced therapeutic applications and vaccine development","author":"Rasetti-Escargueil","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2026.109060_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10051001","article-title":"Recent developments in Botulinum neurotoxins detection","author":"Rasetti-Escargueil","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.toxicon.2026.109060_bib41","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1016\/j.cell.2024.07.035","article-title":"Toward a foundation model of causal cell and tissue biology with a Perturbation Cell and Tissue Atlas","volume":"187","author":"Rood","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.toxicon.2026.109060_bib42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-1331.2006.01438.x","article-title":"Pharmacology of botulinum toxin: differences between type A preparations","volume":"13","author":"Rosales","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.toxicon.2026.109060_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8100276","article-title":"Development of an innovative in vitro potency assay for anti-botulinum antitoxins","volume":"8","author":"Rosen","year":"2016","journal-title":"Toxins"},{"issue":"6","key":"10.1016\/j.toxicon.2026.109060_bib44","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/toxins12060393","article-title":"OnabotulinumtoxinA displays greater biological activity compared to IncobotulinumtoxinA, demonstrating non-interchangeability in both in vitro and in vivo assays","volume":"12","author":"Rupp","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2026.109060_bib45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1353\/pbm.1997.0032","article-title":"Botulinum toxin: the story of its development for the treatment of human disease","volume":"40","author":"Schantz","year":"1997","journal-title":"Perspect. Biol. Med."},{"key":"10.1016\/j.toxicon.2026.109060_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2013.02.014","article-title":"The life history of a botulinum toxin molecule","author":"Simpson","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2026.109060_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.114977","article-title":"Accelerating the optimization of vertical flow assay performance guided by a rational systematic model-based approach","volume":"222","author":"Tay","year":"2023","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.toxicon.2026.109060_bib48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41597-020-0458-y","article-title":"Epigenomic profiling of neuroblastoma cell lines","volume":"7","author":"Upton","year":"2020","journal-title":"Sci. Data"},{"key":"10.1016\/j.toxicon.2026.109060_bib49","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/toxins17090453","article-title":"Research progress on the detection methods of botulinum neurotoxin","volume":"17","author":"Wang","year":"2025","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2026.109060_bib50","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1128\/IAI.00536-13","article-title":"Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and In Vitro","volume":"81","author":"Whitemarsh","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.toxicon.2026.109060_bib51","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/toxins16060279","article-title":"A validation of the equivalence of the cell-based potency assay method with a mouse LD50 bioassay for the potency testing of OnabotulinumtoxinA","volume":"16","author":"Yang","year":"2024","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2026.109060_bib52","doi-asserted-by":"crossref","first-page":"32815","DOI":"10.1074\/jbc.M205258200","article-title":"Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I","volume":"277","author":"Yowler","year":"2002","journal-title":"J. Biol. Chem."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010126000784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010126000784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:02:45Z","timestamp":1773928965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010126000784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":52,"alternative-id":["S0041010126000784"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2026.109060","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A mechanistic computational cell-based potency assay for botulinum neurotoxin A enables transparent potency estimation and cross-assay harmonization","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2026.109060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109060"}}